ARPA-H Archives - EverGlade Consulting

ARPA-H

Blue digitally distorted brain illustration

ARPA-H Announces the Functional Repair of Neocortical Tissue (FRONT) Program

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Functional Repair of Neocortical Tissue (FRONT) Health Science Futures (HSF) Innovative Solutions Opening (ISO) ARPA-H-SOL-25-120 July 10, 2025 Restoring the Damaged Brain: ARPA-H’s FRONT Program Targets Functional Neocortical Repair The Advanced Research Projects Agency for Health (ARPA-H) has announced an ambitious new program under its Health Science Futures (HSF) office: the Functional Repair of Neocortical […]

ARPA-H Announces the Functional Repair of Neocortical Tissue (FRONT) Program Read More »

Medicine manufacturing assembly line.

ARPA-H’s Scalable Solutions ISO

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Mission Office Innovative Solutions Opening (ISO)– ARPA-H-SOL-24-105 – Amendment 02: June 06, 2025 The Advanced Research Projects Agency for Health (ARPA-H) officially released solicitation ARPA-H-SOL-24-105 under its Scalable Solutions Office (SSO), titled Mission Office Innovative Solutions Opening (ISO). This initiative aims to fuel bold, high-impact biomedical and health innovations that tackle persistent barriers in health

ARPA-H’s Scalable Solutions ISO Read More »

Medicine capsules global health with geometric pattern digital r

ARPA-H’s Proactive Health Office ISO Amendment 2

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

PROACTIVE HEALTH OFFICE – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) – ARPA-H-SOL-24-106 – Amendment 02: June 06, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has recently amended the Proactive Health Office (PHO) Innovative Solutions Opening (ISO). The PHO ISO invites novel and disruptive health innovations aimed at extending health spans and improving health

ARPA-H’s Proactive Health Office ISO Amendment 2 Read More »

Doctor holding augmented reality medical-related digital icons

ARPA-H Resilient Systems ISO

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

RESILIENT SYSTEMS OFFICE – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) – ARPA-H-SOL-24-103 – Amendment 02: June 06, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has released Amendment 02 of its Innovative Solutions Opening (ISO) under the Resilient Systems Office (RSO), under Solicitation Number ARPA-H-SOL-24-103. a mission-focused solicitation designed to confront systemic challenges across

ARPA-H Resilient Systems ISO Read More »

Digital composite image of scientific experiment and dNA strands

ARPA-H Health Science Futures ISO

Leave a Comment / ARPA-H, Life Sciences / By

Health Science Futures – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) ARPA-H-SOL-24-104 – Amendment 02: June 06, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has released Amendment 02 of its Health Science Futures (HSF) Mission Office Innovative Solutions Opening (ISO), under Solicitation Number ARPA-H-SOL-24-104. As part of its mission to catalyze high-risk, high-reward research,

ARPA-H Health Science Futures ISO Read More »

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments

Leave a Comment / ARPA-H, Life Sciences / By

On June 6, 2025, the Advanced Research Projects Agency for Health (ARPA-H) issued Amendment 02 to its four flagship Innovation Solutions Opening (ISO) solicitations: Health Science Futures (HSF), Proactive Health Office (PHO), Resilient Systems Office (RSO), and Scalable Solutions Office (SSO). These ISOs represent the core operational arms of ARPA-H’s mission to fund transformative, high-risk,

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments Read More »

The White House Initiatives

White House Unveils New Initiatives for Critical Medicines and Biological Research Safety

Leave a Comment / All Posts, ARPA-H, BARDA, Life Sciences / By

Promoting Domestic Production of Critical Medicines The White House is pushing to see more state-of-the-art pharmaceutical manufacturing facilities within the United States to strengthen the supply of essential medicines. On May 5, 2025, the President signed an Executive Order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines.” The goal of this order is

White House Unveils New Initiatives for Critical Medicines and Biological Research Safety Read More »

PROSPR program

Proactive Solutions for Prolonging Resilience Opportunity Announcement

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

The Foci of PROSPR ARPA-H-SOL-25-125, PROSPR The PROSPR solicitation outlines a comprehensive, multi-year program structured around the development, validation, and deployment of novel health technologies. The program is divided into three primary technical areas (TAs), each addressing a critical component of healthspan extension: TA1 focuses on developing a PROSPR Intrinsic Capacity (IC) score that quantifies

Proactive Solutions for Prolonging Resilience Opportunity Announcement Read More »

ARPA-H_Mission Office Innovative Solutions Openings (ISO)

ARPA-H Mission Office Innovative Solutions Openings (ISOs)

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Overview The Advanced Research Projects Agency for Health (ARPA-H) is dedicated to accelerating transformative health solutions by tackling some of the most pressing challenges in biomedical and healthcare innovation. As part of this mission, ARPA-H has launched Mission Office Innovative Solutions Openings (ISOs) that promote the development of health technologies that lie outside of the

ARPA-H Mission Office Innovative Solutions Openings (ISOs) Read More »

ARPA-H_RAPID rare disease diagnostics

RAPID Solicitation

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

RAPID_SOL_25_119_FINAL Overview The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). The RAPID program aims to significantly improve outcomes for people with rare diseases by reducing diagnostic delays by ≥50%, decreasing misdiagnosis rates, and expanding access to diagnostics. Beyond benefitting the treatment experience of

RAPID Solicitation Read More »

ARPA-H_EIH health and biomedical research

Emerging Health Innovators (EHI) Initiative

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ARPA_H_SOL_25_118_EHI_Solicitation (1) Emerging Health Innovators Solicitation: An Opportunity to Revolutionize Health Innovation The Advanced Research Projects Agency for Health (ARPA-H) has issued the Emerging Health Innovators (EHI) Initiative Solicitation (ARPA-H-SOL-25-118), a groundbreaking funding opportunity aimed at empowering both early-career researchers and community innovators to advance health and biomedical research. Through the EHI Initiative, ARPA-H seeks

Emerging Health Innovators (EHI) Initiative Read More »

ARPA-H, RAPID Funding Alert

EverGlade Consulting Funding Alert: Proposer’s Day for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID)

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

RAPID_Special_Notice ARPA-H’s RAPID Program The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). This initiative aims to revolutionize the prolonged diagnostic odyssey faced by millions of rare disease patients worldwide. Utilizing fragmented datasets and state-of-the-art technologies, RAPID aims to democratize access

EverGlade Consulting Funding Alert: Proposer’s Day for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) Read More »

Scroll to Top